American giant Pfizer, which is linked to German laboratory BioNTech, hopes to get a response from the European Medicines Agency by the end of this month.
01 December 2020 at 15:12
Modified 01 December 2020 in 15:46
The Pfizer / BioNTech Alliance announced Tuesday, December 1, that it has submitted a request for conditional authorization for its vaccine against Covid-19 in the European Union with the European Medicines Agency (EMA).
It will be examined on December 29, according to European regulators.
A “formal request” to the EMA was submitted Monday, November 30, he said in a statement.
Large-scale test results have shown 95% effectiveness of their vaccine.